Clinical Trials
35
Active:22
Completed:1
Trial Phases
4 Phases
Phase 1:23
Phase 2:9
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (35 trials with phase data)• Click on a phase to view related trials
Phase 1
23 (65.7%)Phase 2
9 (25.7%)Not Applicable
1 (2.9%)phase_1_2
1 (2.9%)Phase 3
1 (2.9%)A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma
Phase 1
- Conditions
- Recurrent Adult Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2015-08-11
- Target Recruit Count
- 36
- Registration Number
- NCT01412307
- Locations
- 🇮🇹
Hematology Oncology and Stem Cell Transplantation Unit , IRCCS Fondazione "G.Pascale", Naples, Italy
News
No news found